IP Verse

Cabinet Becker Et Associes patent opposition analysis

The comprehensive analysis of Cabinet Becker Et Associes opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cabinet Becker Et Associes

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3749353	Nemolizumab In The Treatment Of Atopic Dermatitis With Moderate To Severe Excoriation	GALDERMA HOLDING SA	Apr 30, 2026	CABINET BECKER ET ASSOCIES
EP4008329	Isoxazoline Compounds For Use In Treating Demodicosis	INTERVET INTERNATIONAL B.V.	Mar 11, 2026	CEVA SANTE ANIMALE
EP3236960	Use Of Isoxazoline Compounds For Treating Demodicosis	INTERVET INTERNATIONAL B.V.	Oct 28, 2025	CEVA SANTE ANIMALE
EP4013466	Method For In Vitro Production Of Hyaline Cartilage Tissue	VANARIX SA	Jul 16, 2025	CABINET BECKER ET ASSOCIES
EP3790946	Process For Enzymatic Oil Degumming	DSM IP ASSETS B.V.	Jul 8, 2025	CABINET BECKER ET ASSOCIES
EP3485890	Treatment Of Metabolic Disorders In Canine Animals	BOEHRINGER INGELHEIM	Feb 9, 2024	CEVA SANTE ANIMALE
EP3035958	Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine	BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.	Jul 26, 2023	CEVA SANTE ANIMALE
EP3440243	Biodegradable Polyamide Fiber, Process For Obtaining Such Fiber And Polyamide Article Made Therefrom	RHODIA POLIAMIDA E ESPECIALIDADES	Mar 21, 2023	NILIT LTD.
EP3291679	Altering Microbial Populations & Modifying Microbiota	SNIPR TECHNOLOGIES LIMITED	Sep 14, 2022	ELIGO BIOSCIENCE
EP3473101	Isoxazoline Compositions And Their Use As Antiparasitics For Felines	INTERVET	Feb 11, 2022	CEVA SANTE ANIMALE

Top companies who are the clients of Cabinet Becker Et Associes

Company	Total
CEVA SANTE ANIMALE	19
CABINET BECKER ET ASSOCIES	4
SAINT GOBAIN	3
KATZAROV	1
LABORATOIRE FRANCAIS DU FRACTIONNEMENT DES BIOTECHNOLOGIES	1
NILIT LTD.	1
OLYGOSE	1
VALERIE GALLOIS	1
ELIGO BIOSCIENCE	1
JAMES POOLE	1